INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Non-Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹10 Cr | ₹11 Cr | ₹8.97 Cr | ₹8.10 Cr | ₹5.27 Cr |
What is the latest Total Non-Current Assets ratio of INDO US BIOTECH ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹10 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹8.97 Cr |
| Mar2022 | ₹8.10 Cr |
| Mar2021 | ₹5.27 Cr |
How is Total Non-Current Assets of INDO US BIOTECH Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹10 Cr | -2.66 | |
| Mar2024 | ₹11 Cr | 19.34 | |
| Mar2023 | ₹8.97 Cr | 10.73 | |
| Mar2022 | ₹8.10 Cr | 53.68 | |
| Mar2021 | ₹5.27 Cr | - | |
Compare Total Non-Current Assets of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹230.1 Cr | -5% | -8.7% | -58.7% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,583.7 Cr | -3.8% | -4.1% | -12.2% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,591.2 Cr | -6.9% | -8.2% | -2.4% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,271.2 Cr | 2.2% | 11.8% | -13% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,047.8 Cr | -4.5% | 2.6% | -31.6% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹411.0 Cr | -10.8% | -15.9% | -6.8% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -5% |
-8.7% |
-58.7% |
| SENSEX | -1.8% |
-0.6% |
7.3% |
You may also like the below Video Courses